GlassScriptPhysician profile
Margaret R Nettleton
NPI 1710953617
$2,598.51
in general payments reported to CMS, 2019-2025
26 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.95 · 2021: $548 · 2022: $757 · 2023: $775 · 2024: $321 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.81 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $294.28 | 2023-2025 | Myfembree |
| Amgen INC. | $263.17 | 2021-2025 | Evenity, Prolia |
| Aspira Women'S Health INC | $209.65 | 2021-2024 | Ova1 |
| Agile Therapeutics, INC. | $197.62 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $196.34 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $190.29 | 2021-2024 | |
| Pfizer INC. | $160.82 | 2022-2023 | |
| Astellas Pharma US INC | $107.97 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $72.47 | 2022-2025 | Accrufer |
| Organon LLC | $70.70 | 2022-2023 | Nexplanon |
| Avion Pharmaceuticals | $70.35 | 2021-2023 | Balcoltra |
| Therapeuticsmd, INC. | $65.52 | 2021 | |
| Coopersurgical, INC. | $65.38 | 2021-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Hologic Sales and Service, LLC | $50.02 | 2024-2025 | Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $39.81 | 2023 | Bd Max System, Bd Max Instrument |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.42 | 2022 | |
| Exact Sciences Corporation | $31.93 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $31.86 | 2021-2022 | |
| 180 Medical, INC. | $18.95 | 2019 | |
| Scynexis, INC. | $17.29 | 2022 | |
| Channel Medsystems, INC. | $16.87 | 2022 | |
| Gynesonics, INC. | $16.55 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ibsa Pharma INC. | $15.27 | 2022 | |
| Medtronic, INC. | $14.94 | 2022 | |
| Ascend Therapeutics US, LLC | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Nettleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.